Arcturus Therapeutics Newsroom

H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63

Moomoo NewsNov 8 07:35 ET

Arcturus Therapeutics: Strong Buy Rating Backed by Promising Kostaive Sales and Promising Pipeline Developments

TipRanksNov 8 07:25 ET

Buy Rating Justified by Arcturus Therapeutics' Market Potential and Strong Vaccine Efficacy

TipRanksOct 1 12:39 ET

H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63

Moomoo NewsOct 1 12:32 ET

Arcturus Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co.

Dow JonesOct 1 12:22 ET

Arcturus Therapeutics Analyst Ratings

BenzingaOct 1 12:12 ET

Wells Fargo Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $58

Moomoo NewsOct 1 05:31 ET

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Moomoo NewsSep 20 07:31 ET

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Moomoo NewsSep 17 07:34 ET

Leerink Partners Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating

Moomoo NewsSep 13 02:32 ET

Arcturus Therapeutics Analyst Ratings

BenzingaSep 9 12:54 ET

William Blair Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating

Moomoo NewsSep 4 12:32 ET

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Moomoo NewsSep 4 07:31 ET

Buy Rating Affirmed: Arcturus Therapeutics' Promising Cystic Fibrosis Program Progress

TipRanksSep 4 07:11 ET

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Moomoo NewsAug 27 07:35 ET

Arcturus Therapeutics Price Target Announced at $70.00/Share by Leerink Partners

Dow JonesAug 12 07:04 ET

Arcturus Therapeutics Analyst Ratings

BenzingaAug 12 06:52 ET

Arcturus Therapeutics Analyst Ratings

BenzingaAug 8 17:08 ET

Arcturus Therapeutics: Buy Rating Affirmed Amid Kostaive Launch and ARCT-810 Clinical Advancements

TipRanksAug 7 06:45 ET

Arcturus Therapeutics Analyst Ratings

BenzingaAug 6 11:24 ET